RSSS — Research Solutions Income Statement
0.000.00%
Last trade - 00:00- $84.90m
- $80.68m
- $37.70m
- 51
- 34
- 67
- 49
Annual income statement for Research Solutions, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 28.8 | 31.1 | 31.8 | 32.9 | 37.7 |
| Cost of Revenue | |||||
| Gross Profit | 8.34 | 9.64 | 10.3 | 12 | 14.7 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 30 | 31.9 | 32 | 34.6 | 37.5 |
| Operating Profit | -1.25 | -0.852 | -0.283 | -1.63 | 0.239 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.15 | -0.772 | -0.282 | -1.62 | 0.577 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.17 | -0.78 | -0.285 | -1.63 | 0.572 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -0.96 | -0.662 | -0.285 | -1.63 | 0.572 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.96 | -0.662 | -0.285 | -1.63 | 0.572 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.049 | -0.031 | -0.011 | -0.062 | 0.02 |